Back to Trades
Keros Therapeutics, Inc.
KROSCIK: 0001664710
Follow KROS
Track Keros Therapeutics, Inc. insider trades on your dashboard. Email alerts with a subscription.
Keros Therapeutics, Inc. (KROS) has recorded 20 insider filings from 13 unique insiders, totaling $198.5M in trading activity (net selling). Insiders have sold $180.7M while purchasing $10.2K. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is ADAR1 Capital Management, LLC. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$198.5M
Purchases
$10.2K
Sales
$180.7M
Unique Insiders
13
Recent Insider Trades
20 loaded
| Jun 17 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.2K |
| Jun 15 | KROS Keros Therapeutics, Inc. | Newton Charles W. | Insider | Sell | $5.5K |
| Jun 5 | KROS Keros Therapeutics, Inc. | Seth Alpna | Insider | Sell | $28.1K |
| Jun 8 | KROS Keros Therapeutics, Inc. | Knowles Julius | Insider | Sell | $28.2K |
| Jun 8 | KROS Keros Therapeutics, Inc. | Farzan Nima | Insider | Sell | $28.2K |
| Jun 5 | KROS Keros Therapeutics, Inc. | GRAY MARY ANN | Insider | Grant | $0 |
| Jun 5 | KROS Keros Therapeutics, Inc. | Farzan Nima | Insider | Grant | $0 |
| Jun 5 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Grant | $0 |
| Jun 5 | KROS Keros Therapeutics, Inc. | Seth Alpna | Insider | Grant | $0 |
| Jun 5 | KROS Keros Therapeutics, Inc. | Knowles Julius | Insider | Grant | $0 |
| Apr 6 | KROS Keros Therapeutics, Inc. | Seehra Jasbir | Insider | Other | $0 |
| Jan 9 | KROS Keros Therapeutics, Inc. | Seehra Jasbir | Insider | Other | $0 |
| Dec 18 | KROS Keros Therapeutics, Inc. | GORDON CARL L | Director | Other | $0 |
| Dec 18 | KROS Keros Therapeutics, Inc. | Knowles Julius | Insider | Other | $0 |
| Dec 18 | KROS Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Other | $0 |
| Oct 15 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | Sell | $95.7M |
| Oct 17 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Sell | $85.0M |
| Sep 5 | KROS Keros Therapeutics, Inc. | Seehra Jasbir | Insider | Grant | $0 |
| Aug 15 | KROS Keros Therapeutics, Inc. | Cho Esther | Insider | Other | $0 |
| Aug 15 | KROS Keros Therapeutics, Inc. | Lerner Lorena Raquel | Insider | Other | $0 |
20 filings